By Maggie Fick

Summary:

– AstraZeneca secures U.S. deal to lower drug prices and avoid tariffs .

– Company will build a $4.5 billion Virginia plant to expand manufacturing .

– CEO Pascal Soriot leveraged relationships with Trump officials and Gov. Glenn Youngkin.

LONDON — AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of Americans.

The hard work had paid off, allowing Soriot to clinch the first agreement for a non-U.S. drugmaker and shield his Anglo-Swedish company from threatened steep tariffs on imports to the U.S. – the world’s largest pharmaceuticals market.

That moment at the White House was the culmination of public and private meet

See Full Page